Ultrasound Therapy and Manual Therapy in Digital Ischemic Ulcers
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05907200 |
Recruitment Status :
Completed
First Posted : June 18, 2023
Last Update Posted : June 22, 2023
|
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
The objective of this before-after non-randomized trial study is to evaluate the efficacy of ultrasound therapy in combination with manual therapy in the management of systemic sclerosis patients with IDU. The main questions it intends to answer are:
• Is this combination of treatments effective in these patients in terms of improvement in hand functional ability, pain relief, injury healing, and quality of life?
Participants will receive rehabilitation treatment consisting of a combination of manual therapy (McMennel joint manipulation, pumping, and connective tissue massage) and US water immersion. The researchers will compare the group of participants, called the treatment group, with a control group to see if:
• Is the combined treatment of ultrasound therapy and manual therapy more effective in these patients than manual therapy alone?
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Systemic Sclerosis | Other: combination ultrasound therapy and manual therapy Other: manual therapy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 45 participants |
Allocation: | Non-Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Treatment |
Official Title: | Ultrasound in Combination With Manual Therapy in the Treatment of Ischemic Digital Ulcers in Systemic Sclerosis |
Actual Study Start Date : | April 1, 2022 |
Actual Primary Completion Date : | November 30, 2022 |
Actual Study Completion Date : | December 15, 2022 |
Arm | Intervention/treatment |
---|---|
Experimental: Treatment Group
It received rehabilitation treatment consisting of a combination of manual therapy (McMennel joint manipulation, pumping and connective tissue massage) and US water immersion.
|
Other: combination ultrasound therapy and manual therapy
The proposed manual therapy lasted 90 minutes and involved a combination of three different techniques: McMennel manipulation, connective tissue massage and mobilization technique of pumping. Patients in the treatment group also received a treatment with US (I-Tech medical device certified UT2 CE0476) in combination with manual therapy. Dipping technique was applied with a frequency of 1 MHz, intensity of 1W/cm2, duty cycle of 60% and a duration of 15 minutes per session. |
Placebo Comparator: Control Group
It received rehabilitation treatment consisting of manual therapy alone
|
Other: manual therapy
manual treatment lasting 90 minutes which involved a combination of three different techniques: McMennel manipulation, connective tissue massage and pumping mobilization technique. |
- functional capacity [ Time Frame: after 4 weeks of treatment ]Duruoz's hand index. The total score ranges from 0-90 with higher scores indicating poorer hand functioning.
- pain intensity [ Time Frame: after 4 weeks of treatment ]numerical rating scale; the total score ranges from 0 to 10, with higher scores indicating more pain.
- ulcer assessment [ Time Frame: after 4 weeks of treatment ]Pressure Sore Status Tool; The score is between 13 and 65. Higher total scores indicated more severe wound status.
- disease-related quality of life [ Time Frame: after 4 weeks of treatment ]The 36-Item Short Form Health Survey; The score ranges from 0 to 100, where higher scores indicate improved health.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 30 Years to 60 Years (Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- diagnosis of SSc according to the ACR and EULAR criteria
- presence of IDU in active phase
- naïve to rehabilitation treatment for their hands and upper limbs
- written in-formed consent to participate in the study.
Exclusion Criteria:
- presence of skin lesions due to other conditions (e.g., trauma);
- pregnancy;
- infectious diseases (e.g. HIV, HBV, HCV);
- myositis;
- arthritis;
- other rheumatological diseases and immunodepression.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05907200
Italy | |
Functional Recovery and Rehabilitation Unit of the A.O.U.P. Paolo Giaccone | |
Palermo, Italy, 90127 |
Responsible Party: | Prof.ssa Giulia Letizia Mauro, Professor, University of Palermo |
ClinicalTrials.gov Identifier: | NCT05907200 |
Other Study ID Numbers: |
MFR0022023 |
First Posted: | June 18, 2023 Key Record Dates |
Last Update Posted: | June 22, 2023 |
Last Verified: | June 2023 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Product Manufactured in and Exported from the U.S.: | Yes |
rehabilitation skin ulcer ultrasound therapy disability |
Scleroderma, Systemic Scleroderma, Diffuse Sclerosis |
Pathologic Processes Connective Tissue Diseases Skin Diseases |